CompletedNot Applicable

Safety and Feasibility of the Infinity Catheter for Radial Access

United States80 participantsStarted 2020-10-01

Plain-language summary

The main objective of this single arm study is to evaluate the safety and feasibility of the AXS Infinity LS (Stryker, Freemont, CA, USA) and AXS Infinity LS Plus (Stryker, Freemont, CA, USA) catheters during the transradial approach through a secondary use of the data collected during neurointerventional procedures. This includes evaluating the conversion rates to a transfemoral approach. A secondary aim of the study is to assess the radial artery occlusion rates post procedure.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age group 18 years and above. * Patients undergoing neuro-embolization using large bore catheters Exclusion Criteria: * Patients with Radial artery diameter less than 2.4 mm measured with Ultrasound * Age\<18 * Patients who have previous surgeries at either approach site which precludes the use of one of the approach sites * Patients who has poor collateral circulation, Raynaud's phenomenon, radial loop, brachial or subclavian stenosis, aberrant origin of the subclavian artery * Pregnant patients

What they're measuring

Feasibility of TRA Intervention

Timeframe: 1 month

Trial details

NCT IDNCT04553549

SponsorRutgers, The State University of New Jersey

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09-15

View on ClinicalTrials.gov More Brain Tumor trials